Omicron variant study could contribute to future vaccine development

  • December 13, 2022
Omicron variant study could contribute to future vaccine development

Antonia Netzl is co-author of a study on Covid variants which has implications for vaccine development

Our work presents an important contribution to the discussion on vaccine updates to improve protection against current and future emerging SARS-CoV-2 variants.

Antonia Netzl et al

All the omicron strains are different from the original COVID infection and from each other, but repeated exposure to pre-omicron variants can protect against omicron variants, according to a new study which has implications for further vaccine development.

The study, BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variants, is published in Nature Communications today and is co-authored by Gates Cambridge Scholar Antonia Netzl.

It looked at the original omicron variant [BA.1] and sought to compare whether the BA.2 and BA.5 sub-variants which soon replaced it in many countries were more resistant to COVID vaccines.

Using people with differing histories of exposure to infection and vaccination, they found that unvaccinated people had limited cross-neutralising antibodies to pre-omicron variants and BA.1 after a single exposure to BA.2.

By mapping all variants of concern and the omicron sub-variants, they showed that all the omicron sub-variants are distinct to pre-omicron variants, but that the three omicron variants are also antigenically distinct from each other.

Moreover, antibodies that can fight the virus are only generated after three or more exposures to antigenically close variants and also after two exposures to antigenically distant variants.

They say: “Our work presents an important contribution to the discussion on vaccine updates to improve protection against current and future emerging SARS-CoV-2 variants. It suggests that cross-neutralisation improves with repeated exposure and an increase in absolute titers of antibodies and that exposure to two distant variants has protective potential against emerging variants with some degree of similarity to currently and previously circulating Variants of Concern.”

*Picture credit: https://www.vperemen.comCC BY-SA 4.0 and Wikimedia Commons.

 

Latest News

Scholar makes Forbes 30 Under 30 Healthcare & Science list in Asia

A Gates Cambridge Scholar has been featured as one of Forbes 30 Under 30 Asia: Healthcare & Science list. Hoang Minh Hieu Nguyen is one of 18 scientists and researchers […]

Studying Indigenous attitudes to mental health

When Will Smith [2026]  was studying in Canada during his undergraduate degree, his lecturer, Professor Pablo Irizar, on a Mexican philosophy course took a different approach to the subject of […]

Using Computational Chemistry to make better therapeutics

Aidyn Taishybay [2026] believes firmly that science should make a tangible difference to people.  He wants his work to have direct impact in the world and to make medicines more […]

How do we lead with hope?

Two Gates Cambridge Scholars feature in the final episode of the third series of our podcast So, now what? with a discussion about how to lead with hope. This series […]